We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Pharmaceutical Sciences and Drug Design

2022 Volume 2

Chemometric-Based UV Spectrophotometric Approach for the Estimation of a Newly Developed Anti-Tubercular Liquisolid Formulation


, , ,
  1. Department of Medicinal Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
Abstract

This study proposes a numerical approach based on spectroscopic data combined with partial least squares (PLS) multivariate analysis to simultaneously quantify quercetin and rifampicin in raw materials and liquisolid formulations. Spectral measurements were obtained for rifampicin and quercetin over a linear concentration range of 2–10 µg/ml for each compound. A total of 25 simulated mixtures were generated, including 16 calibration and 9 validation sets, using a wavelength interval of λ = 15 nm in 0.1 M hydrochloric acid and phosphate buffer at pH = 6.8, covering the spectral range of 200 to 630 nm. The suitability of the models was evaluated based on the root mean square errors (RMSE) obtained from the calibration and validation data sets. The analytical performance was further evaluated by comparing recovery percentages and relative prediction errors across different chemometric techniques. The results of the recovery analysis confirmed that this method effectively enabled pharmaceutical formulation without the interference of excipients. The proposed approach is rapid, user-friendly, and serves as a viable alternative to conventional analytical methods for formulation development and pharmaceutical quality control.


How to cite this article
Vancouver
El-adl SM, El-Shanawani AA, Madbouly EA, Abdelkhalek AS. Chemometric-Based UV Spectrophotometric Approach for the Estimation of a Newly Developed Anti-Tubercular Liquisolid Formulation. Pharm Sci Drug Des. 2022;2:52-60. https://doi.org/10.51847/ZWp4pSaVXX
APA
El-adl, S. M., El-Shanawani, A. A., Madbouly, E. A., & Abdelkhalek, A. S. (2022). Chemometric-Based UV Spectrophotometric Approach for the Estimation of a Newly Developed Anti-Tubercular Liquisolid Formulation. Pharmaceutical Sciences and Drug Design, 2, 52-60. https://doi.org/10.51847/ZWp4pSaVXX

About GalaxyPub

Find out more

Galaxy Publication is an independent scholarly publishing platform operating under the scientific and organizational designation of Eshragh Scientific and Research Center and the legal framework of ISRAK PUBLISHER EGITIM HIZMETLERI LIMITED.

The publisher is committed to ethical, transparent, and high-quality academic publishing and supports scholarly communication through internationally aligned editorial practices, publication ethics, and responsible dissemination of scientific research.